医療画像試薬の市場規模、シェア、成長分析、クラス別、モダリティ別、技術別、用途別、地域別 - 産業予測 2025-2032年

医療画像試薬市場規模は2023年に173億5,000万米ドルと評価され、2024年の182億5,000万米ドルから2032年には273億8,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは5.2％で成長する見通しです。

科学画像試薬の世界市場は、診断や研究に不可欠なツールを提供する、ヘルスケアの重要な構成要素です。これらの試薬は、MRI、CT、超音波、核医学などの医療用画像診断において、組織や臓器の可視性を高める。主な市場促進要因としては、慢性疾患の罹患率の上昇、人口の高齢化、正確な早期診断に対するニーズの高まりなどが挙げられます。その結果、医療画像試薬は診断精度と治療計画を大幅に向上させ、患者の予後を改善します。最近の動向では、詳細な機能情報や代謝情報を提供する分子イメージング技術への注目が高まっており、特定の分子を標的とする高度な試薬への需要が高まっています。また、ハイブリッドイメージングシステムの台頭により、複数のモダリティに適応可能な汎用性の高い試薬が必要とされています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術分析

医療画像試薬市場規模：クラス別& CAGR（2025-2032）

• 市場概要
• 造影剤
• 光学試薬
• 核試薬

医療画像試薬市場規模：モダリティ別& CAGR（2025-2032）

• 市場概要
• X線
• CTスキャン
• 超音波
• MRIスキャン

医療画像試薬市場規模：技術別& CAGR（2025-2032）

• 市場概要
• ナノ粒子
• 蛍光色素とプローブ
• 放射性医薬品
• 蛍光タンパク質
• 量子ドット

医療画像試薬市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 診断
• 医薬品の発見と開発
• 教育調査

医療画像試薬市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• GE Healthcare（USA）
• Siemens Healthineers（Germany）
• Bracco Imaging S.p.A.（Italy）
• Bayer AG（Germany）
• Guerbet Group（France）
• Lantheus Holdings Inc.（USA）
• Jubilant Radiopharma（India）
• Cardinal Health Inc.（USA）
• Nordion（Canada）Inc.（Canada）
• Curium Pharma（France）
• Advanced Accelerator Applications（AAA）-A Novartis Company（Switzerland）
• Eli Lilly and Company（USA）
• Thermo Fisher Scientific Inc.（USA）
• PerkinElmer Inc.（USA）
• Agfa-Gevaert Group（Belgium）
• Merck KGaA（Germany）
• Triad Isotopes Inc.（USA）
• Nihon Medi-Physics Co. Ltd.（Japan）
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.（China）
• EczacIbasI-Monrol Nuclear Products（Turkey）

結論と提言

Medical Imaging Reagents Market size was valued at USD 17.35 billion in 2023 and is poised to grow from USD 18.25 billion in 2024 to USD 27.38 billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The global scientific imaging reagents market is a vital component of the healthcare landscape, providing essential tools for diagnostics and research. These reagents enhance the visibility of tissues and organs in medical imaging modalities like MRI, CT, ultrasound, and nuclear medicine. Key market drivers include the rising incidence of chronic illnesses, an aging population, and the increasing need for precise early diagnosis. As a result, medical imaging reagents significantly enhance diagnostic accuracy and treatment planning, improving patient outcomes. Recent trends indicate a growing focus on molecular imaging techniques that offer detailed functional and metabolic information, driving demand for advanced reagents targeting specific molecules. Ongoing R&D efforts aim to create safer, more efficient reagents, while the rise of hybrid imaging systems necessitates versatile reagents adaptable to multiple modalities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Medical Imaging Reagents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Medical Imaging Reagents Market Segments Analysis

Global Medical Imaging Reagents Market is segmented by Class, Modality, Technology, Application and region. Based on Class, the market is segmented into Contrast reagents, Optical reagents and Nuclear reagents. Based on Modality, the market is segmented into X-ray, CT Scan, Ultrasound and MRI Scan. Based on Technology, the market is segmented into Nanoparticles, Fluorescent dyes & probes, Radiopharmaceuticals, Fluorescent proteins and Quantum dots. Based on Application, the market is segmented into Diagnostics, Drug discovery & development and Educational Research. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Medical Imaging Reagents Market

The rising incidence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has led to an escalating demand for medical imaging procedures. This growing healthcare need places significant importance on medical imaging reagents, which enhance the precision and efficacy of diagnostic imaging techniques. Consequently, their crucial role in facilitating accurate diagnoses is driving increased adoption across healthcare facilities. As the healthcare sector continues to evolve and adapt to the growing prevalence of these health issues, the demand for reliable medical imaging reagents is expected to surge, further supporting advancements in diagnostic technologies and ultimately improving patient outcomes.

Restraints in the Medical Imaging Reagents Market

The Medical Imaging Reagents market faces significant restraints, particularly due to the high costs associated with advanced imaging techniques such as PET and MRI. These expenses not only encompass the reagents themselves but also the necessary equipment and related healthcare services, creating a substantial financial burden for both healthcare facilities and patients. This pricing challenge can hinder market growth, particularly in economically disadvantaged regions where access to such advanced imaging technologies is limited. Consequently, the affordability and overall economic dynamics of the healthcare system are crucial factors influencing the uptake and expansion of medical imaging reagents in various markets.

Market Trends of the Medical Imaging Reagents Market

The Medical Imaging Reagents market is witnessing a robust trend driven by the surging demand for molecular imaging agents, particularly positron emission tomography (PET) and single-photon emission computed tomography (SPECT) radiopharmaceuticals. These innovative reagents facilitate precise visualization and quantification of biological processes at the molecular and cellular levels, proving essential for early disease detection, treatment planning, and monitoring. Significant advancements in the development of radiopharmaceuticals-focused on enhancing specificity and targeting-are further propelling this demand. This trend underscores the healthcare sector's shift towards personalized medicine, with molecular imaging playing a pivotal role in diagnosing and managing complex diseases effectively.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis

Global Medical Imaging Reagents Market Size by Class & CAGR (2025-2032)

• Market Overview
• Contrast reagents
• Optical reagents
• Nuclear reagents

Global Medical Imaging Reagents Market Size by Modality & CAGR (2025-2032)

• Market Overview
• X-ray
• CT Scan
• Ultrasound
• MRI Scan

Global Medical Imaging Reagents Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Nanoparticles
• Fluorescent dyes & probes
• Radiopharmaceuticals
• Fluorescent proteins
• Quantum dots

Global Medical Imaging Reagents Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnostics
• Drug discovery & development
• Educational Research

Global Medical Imaging Reagents Market Size & CAGR (2025-2032)

• North America (Class, Modality, Technology, Application)
  • US
  • Canada
• Europe (Class, Modality, Technology, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Class, Modality, Technology, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Class, Modality, Technology, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Class, Modality, Technology, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guerbet Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Radiopharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nordion (Canada) Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curium Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Accelerator Applications (AAA) - A Novartis Company (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agfa-Gevaert Group (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Triad Isotopes Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Medi-Physics Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EczacIbasI-Monrol Nuclear Products (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations